Literature DB >> 26793331

Chronic outpatient management of patients with a left ventricular assist device.

Elisa M Smith1, Jennifer Franzwa1.   

Abstract

The use of mechanical circulatory support (MCS) as treatment for advanced heart failure (HF) has grown exponentially over the past 15 years. The continuous flow left ventricular assist device (CF-LVAD) has become the most used form of MCS in advanced HF, especially since approval of use as destination therapy (DT) and with the lack of organ availability. Long-term survival has improved and diligent outpatient management is thus particularly critical to achieve optimal outcomes. This review will discuss outpatient management strategies for patients with HF and a left ventricular assist device (LVAD).

Entities:  

Keywords:  Chronic outpatient management; heart failure (HF); left ventricular assist device (LVAD)

Year:  2015        PMID: 26793331      PMCID: PMC4703652          DOI: 10.3978/j.issn.2072-1439.2015.10.28

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  62 in total

1.  Fibrinolytic activation during long-term support with the HeartMate II left ventricular assist device.

Authors:  Mark S Slaughter; Michael A Sobieski; Colleen Gallagher; Joel Graham; Joseph Brandise; Robert Stein
Journal:  ASAIO J       Date:  2008 Jan-Feb       Impact factor: 2.872

2.  Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation.

Authors:  Keith D Aaronson; Mark S Slaughter; Leslie W Miller; Edwin C McGee; William G Cotts; Michael A Acker; Mariell L Jessup; Igor D Gregoric; Pranav Loyalka; O H Frazier; Valluvan Jeevanandam; Allen S Anderson; Robert L Kormos; Jeffrey J Teuteberg; Wayne C Levy; David C Naftel; Richard M Bittman; Francis D Pagani; David R Hathaway; Steven W Boyce
Journal:  Circulation       Date:  2012-05-22       Impact factor: 29.690

Review 3.  Management of aortic insufficiency in the continuous flow left ventricular assist device population.

Authors:  Jonathan Holtz; Jeffrey Teuteberg
Journal:  Curr Heart Fail Rep       Date:  2014-03

4.  The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary.

Authors:  David Feldman; Salpy V Pamboukian; Jeffrey J Teuteberg; Emma Birks; Katherine Lietz; Stephanie A Moore; Jeffrey A Morgan; Francisco Arabia; Mary E Bauman; Hoger W Buchholz; Mario Deng; Marc L Dickstein; Aly El-Banayosy; Tonya Elliot; Daniel J Goldstein; Kathleen L Grady; Kylie Jones; Katarzyna Hryniewicz; Ranjit John; Annemarie Kaan; Shimon Kusne; Matthias Loebe; M Patricia Massicotte; Nader Moazami; Paul Mohacsi; Martha Mooney; Thomas Nelson; Francis Pagani; William Perry; Evgenij V Potapov; J Eduardo Rame; Stuart D Russell; Erik N Sorensen; Benjamin Sun; Martin Strueber; Abeel A Mangi; Michael G Petty; Joseph Rogers
Journal:  J Heart Lung Transplant       Date:  2013-02       Impact factor: 10.247

5.  Sexual function after left ventricular assist device.

Authors:  Peter M Eckman; Vinayak Dhungel; Stacy Mandras; Meredith A Brisco; Sitaramesh Emani; Sue Duval; Joann Lindenfeld; Nasir Sulemanjee; George G Sokos; Jamie Feldman
Journal:  J Am Coll Cardiol       Date:  2013-03-14       Impact factor: 24.094

6.  Unexpected abrupt increase in left ventricular assist device thrombosis.

Authors:  Randall C Starling; Nader Moazami; Scott C Silvestry; Gregory Ewald; Joseph G Rogers; Carmelo A Milano; J Eduardo Rame; Michael A Acker; Eugene H Blackstone; John Ehrlinger; Lucy Thuita; Maria M Mountis; Edward G Soltesz; Bruce W Lytle; Nicholas G Smedira
Journal:  N Engl J Med       Date:  2013-11-27       Impact factor: 91.245

Review 7.  Current concepts in the diagnosis and management of left ventricular assist device infections.

Authors:  Juhsien Nienaber; Mark P Wilhelm; M Rizwan Sohail
Journal:  Expert Rev Anti Infect Ther       Date:  2013-02       Impact factor: 5.091

8.  Validity and reliability of a novel slow cuff-deflation system for noninvasive blood pressure monitoring in patients with continuous-flow left ventricular assist device.

Authors:  Gregg M Lanier; Khristine Orlanes; Yacki Hayashi; Jennifer Murphy; Margaret Flannery; Rosie Te-Frey; Nir Uriel; Melana Yuzefpolskaya; Donna M Mancini; Yoshifumi Naka; Hiroo Takayama; Ulrich P Jorde; Ryan T Demmer; Paolo C Colombo
Journal:  Circ Heart Fail       Date:  2013-06-27       Impact factor: 8.790

Review 9.  Hypertension: an unstudied potential risk factor for adverse outcomes during continuous flow ventricular assist device support.

Authors:  Lauren T Wasson; Melana Yuzefpolskaya; Michiyori Wakabayashi; Hiroo Takayama; Yoshifumi Naka; Nir Uriel; Ulrich P Jorde; Ryan T Demmer; Paolo C Colombo
Journal:  Heart Fail Rev       Date:  2015-05       Impact factor: 4.214

10.  Haemolysis in patients with ventricular assist devices: major differences between systems.

Authors:  Claudia Heilmann; Ulrich Geisen; Christoph Benk; Michael Berchtold-Herz; Georg Trummer; Christian Schlensak; Barbara Zieger; Friedhelm Beyersdorf
Journal:  Eur J Cardiothorac Surg       Date:  2009-05-22       Impact factor: 4.191

View more
  3 in total

1.  Development and Feasibility of Self-Management Application in Left-Ventricular Assist Devices.

Authors:  Jesus M Casida; James E Aikens; Heidi Craddock; Matthew W Aldrich; Francis D Pagani
Journal:  ASAIO J       Date:  2018 Mar/Apr       Impact factor: 2.872

Review 2.  Ventricular Assist Device-Specific Infections.

Authors:  Yue Qu; Anton Y Peleg; David McGiffin
Journal:  J Clin Med       Date:  2021-01-25       Impact factor: 4.241

3.  Nanocomposite Hydrogel with Tantalum Microparticles for Rapid Endovascular Hemostasis.

Authors:  Hassan Albadawi; Izzet Altun; Jingjie Hu; Zefu Zhang; Anshuman Panda; Han-Jun Kim; Ali Khademhosseini; Rahmi Oklu
Journal:  Adv Sci (Weinh)       Date:  2020-11-30       Impact factor: 16.806

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.